Johnson Dunn Capital Advisors Inc’s Bristol-Myers Squibb BMY Stock Holding History

Johnson Dunn Capital Advisors Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$858K	Buy	+13,758	New	+$869K	0.61%	46

Other funds holding BMY

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Johnson Dunn Capital Advisors Inc's BMY Position: Q3 2026 in Review

Johnson Dunn Capital Advisors Inc opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 13,758 shares worth $858K. The stake represents 0.61% of the portfolio and ranks #46 among its holdings.

2,009 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Johnson Dunn Capital Advisors Inc held 13,758 shares of Bristol-Myers Squibb worth $858K as of Q3 2026.
Bristol-Myers Squibb was a new Johnson Dunn Capital Advisors Inc position in Q3 2026.
Bristol-Myers Squibb made up 0.61% of Johnson Dunn Capital Advisors Inc's portfolio in Q3 2026, its #46 holding.
2,009 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Johnson Dunn Capital Advisors Inc's 13F filing for Q3 2026, filed 12 Nov 2026.